Former Gov. Chris Christie brought significant attention to the crisis and Gov. Phil Murphy has fine-tuned the response, with new investments to support data collection, community based treatment providers, and addressing the underlying causes of addiction.
But the opioid-related deaths continue to climb, in part because of powerful new drug cocktails; more than 2,000 state residents have already died of drug-related issues this year, double the mortality rate of 2016.
Opening Remarks
Mariel S. Hufnagel, Executive Director, The Ammon Foundation, a philanthropic endeavor of Ammon Labs
Panelists
Robert J. Budsock, MS, LCADC, President & CEO, Integrity House
Petros Levounis, MD, MA, Professor and Chair, Department of Psychiatry,
Rutgers New Jersey Medical School; Chief of Service, University Hospital, Newark
Eric McIntire, Assistant Director Recovery Support Services, RWJBarnabas
Health Institute for Prevention and Recovery
Ken Pecoraro, LCSW, LCADC, CCS, Director of Addiction and Co-Occuring Services,
CPC Behavioral Healthcare
Senator Joseph F. Vitale, (D-Middlesex), Chair, Senate Health, Human Services &
Senior Citizens Committee, Vice-Chair, Labor Committee, New Jersey Senate
Moderator
Lilo H. Stainton, Healthcare Reporter, NJ Spotlight
Related Editorial
Different Prescriptions for Long-Term Recovery from Opioid Addiction
Sponsors


